메뉴 건너뛰기




Volumn 68, Issue 8, 2014, Pages 332-343

Genome-wide microarray analysis identifies a potential role for striatal retrograde endocannabinoid signaling in the pathogenesis of experimental l-DOPA-induced dyskinesia

Author keywords

Dyskinesia; Endocannabinoid; l DOPA; Microarray; Parkinson's disease

Indexed keywords

ENDOCANNABINOID; LEVODOPA; NEUROTRANSMITTER RECEPTOR; POSTSYNAPTIC RECEPTOR; SYNAPSE RECEPTOR; ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIPARKINSON AGENT; OXIDOPAMINE;

EID: 84902314346     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.21740     Document Type: Article
Times cited : (14)

References (54)
  • 3
    • 0035889980 scopus 로고    scopus 로고
    • Expression of cGMP-specific phosphodiesterase 9A mRNA in the rat brain
    • Andreeva SG, Dikkes P, Epstein PM, Rosenberg PA. 2001. Expression of cGMP-specific phosphodiesterase 9A mRNA in the rat brain. J Neurosci 21:9068-9076.
    • (2001) J Neurosci , vol.21 , pp. 9068-9076
    • Andreeva, S.G.1    Dikkes, P.2    Epstein, P.M.3    Rosenberg, P.A.4
  • 5
    • 0035932974 scopus 로고    scopus 로고
    • Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets
    • Berger A, Crozier G, Bisogno T, Cavaliere P, Innis S, Di Marzo V. 2001. Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets. Proc Natl Acad Sci USA 98:6402-6406.
    • (2001) Proc Natl Acad Sci USA , vol.98 , pp. 6402-6406
    • Berger, A.1    Crozier, G.2    Bisogno, T.3    Cavaliere, P.4    Innis, S.5    Di Marzo, V.6
  • 6
    • 0035434121 scopus 로고    scopus 로고
    • Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies
    • Bezard E, Brotchie JM, Gross CE. 2001. Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies. Nat Rev Neurosci 2:577-588.
    • (2001) Nat Rev Neurosci , vol.2 , pp. 577-588
    • Bezard, E.1    Brotchie, J.M.2    Gross, C.E.3
  • 7
    • 0034287012 scopus 로고    scopus 로고
    • Functional changes of the basal ganglia circuitry in Parkinson's disease
    • Blandini F, Nappi G, Tassorelli C, Martignoni E. 2000. Functional changes of the basal ganglia circuitry in Parkinson's disease. Prog Neurobiol 62:63-88.
    • (2000) Prog Neurobiol , vol.62 , pp. 63-88
    • Blandini, F.1    Nappi, G.2    Tassorelli, C.3    Martignoni, E.4
  • 9
    • 0035784037 scopus 로고    scopus 로고
    • Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal activity of the pedunculopontine nucleus, which is reversed by the lesion of the subthalamic nucleus in the rat
    • Breit S, Bouali-Benazzouz R, Benabid A, Benazzouz A. 2001. Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal activity of the pedunculopontine nucleus, which is reversed by the lesion of the subthalamic nucleus in the rat. Eur J Neurosci 14:1833-1842.
    • (2001) Eur J Neurosci , vol.14 , pp. 1833-1842
    • Breit, S.1    Bouali-Benazzouz, R.2    Benabid, A.3    Benazzouz, A.4
  • 10
    • 53149129843 scopus 로고    scopus 로고
    • Molecular mechanisms underlying levodopa-induced dyskinesia
    • Calabresi P, Di Filippo M, Ghiglieri V, Picconi B. 2008. Molecular mechanisms underlying levodopa-induced dyskinesia. Mov Disord 23 (Suppl 3):S570-S579.
    • (2008) Mov Disord , vol.23 , Issue.SUPPL 3
    • Calabresi, P.1    Di Filippo, M.2    Ghiglieri, V.3    Picconi, B.4
  • 11
    • 77957966489 scopus 로고    scopus 로고
    • Levodopa-induced dyskinesias in patients with Parkinson's disease: Filling the bench-to-bedside gap
    • Calabresi P, Di Filippo M, Ghiglieri V, Tambasco N, Picconi B. 2010. Levodopa-induced dyskinesias in patients with Parkinson's disease: Filling the bench-to-bedside gap. Lancet Neurol 9:1106-1117.
    • (2010) Lancet Neurol , vol.9 , pp. 1106-1117
    • Calabresi, P.1    Di Filippo, M.2    Ghiglieri, V.3    Tambasco, N.4    Picconi, B.5
  • 12
    • 0000428532 scopus 로고
    • 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists
    • Carlsson A, Lindqvist M, Magnusson T. 1957. 3, 4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature 180:1200.
    • (1957) Nature , vol.180 , pp. 1200
    • Carlsson, A.1    Lindqvist, M.2    Magnusson, T.3
  • 14
    • 84885107433 scopus 로고    scopus 로고
    • Temporal changes of CB1 cannabinoid receptor in the basal ganglia as a possible structure-specific plasticity process in 6-OHDA lesioned rats
    • Chaves-Kirsten GP, Mazucanti CH, Real CC, Souza BM, Britto LR, Torrão AS. 2013. Temporal changes of CB1 cannabinoid receptor in the basal ganglia as a possible structure-specific plasticity process in 6-OHDA lesioned rats. PLoS One 8:e76874.
    • (2013) PLoS One , vol.8
    • Chaves-Kirsten, G.P.1    Mazucanti, C.H.2    Real, C.C.3    Souza, B.M.4    Britto, L.R.5    Torrão, A.S.6
  • 15
    • 27944470972 scopus 로고    scopus 로고
    • Metabotropic glutamate receptors in the basal ganglia motor circuit
    • Conn PJ, Battaglia G, Marino MJ, Nicoletti F. 2005. Metabotropic glutamate receptors in the basal ganglia motor circuit. Nat Rev Neurosci 6:787-798.
    • (2005) Nat Rev Neurosci , vol.6 , pp. 787-798
    • Conn, P.J.1    Battaglia, G.2    Marino, M.J.3    Nicoletti, F.4
  • 16
    • 0036283426 scopus 로고    scopus 로고
    • Modeling Parkinson's disease in rats: An evaluation of 6-OHDA lesions of the nigrostriatal pathway
    • Deumens R, Blokland A, Prickaerts J. 2002. Modeling Parkinson's disease in rats: An evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp Neurol 175:303-317.
    • (2002) Exp Neurol , vol.175 , pp. 303-317
    • Deumens, R.1    Blokland, A.2    Prickaerts, J.3
  • 17
    • 0033936028 scopus 로고    scopus 로고
    • Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease
    • Di Marzo V, Hill MP, Bisogno T, Crossman AR, Brotchie JM. 2000. Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease. FASEB J 14:1432-1438.
    • (2000) FASEB J , vol.14 , pp. 1432-1438
    • Di Marzo, V.1    Hill, M.P.2    Bisogno, T.3    Crossman, A.R.4    Brotchie, J.M.5
  • 18
    • 35348890683 scopus 로고    scopus 로고
    • On testing the significance of sets of genes
    • Efron B, Tibshirani R. 2007. On testing the significance of sets of genes. Ann Appl Stat 1:107-129.
    • (2007) Ann Appl Stat , vol.1 , pp. 107-129
    • Efron, B.1    Tibshirani, R.2
  • 19
    • 0034109726 scopus 로고    scopus 로고
    • The spectrum of levodopa-induced dyskinesias
    • discussion S9-S11.
    • Fahn S. 2000. The spectrum of levodopa-induced dyskinesias. Ann Neurol 47(Suppl 1):S2-S9; discussion S9-S11.
    • (2000) Ann Neurol , vol.47 , Issue.SUPPL 1
    • Fahn, S.1
  • 20
    • 0034653210 scopus 로고    scopus 로고
    • Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia
    • Fenton WS, Hibbeln J, Knable M. 2000. Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia. Biol Psychiatry 47:8-21.
    • (2000) Biol Psychiatry , vol.47 , pp. 8-21
    • Fenton, W.S.1    Hibbeln, J.2    Knable, M.3
  • 21
    • 0141481993 scopus 로고    scopus 로고
    • Effects of levodopa on endocannabinoid levels in rat basal ganglia: Implications for the treatment of levodopa-induced dyskinesias
    • Ferrer B, Asbrock N, Kathuria S, Piomelli D, Giuffrida A. 2003. Effects of levodopa on endocannabinoid levels in rat basal ganglia: Implications for the treatment of levodopa-induced dyskinesias. Eur J Neurosci 18:1607-1614.
    • (2003) Eur J Neurosci , vol.18 , pp. 1607-1614
    • Ferrer, B.1    Asbrock, N.2    Kathuria, S.3    Piomelli, D.4    Giuffrida, A.5
  • 22
    • 52449135495 scopus 로고    scopus 로고
    • Pathophysiology of parkinsonism
    • Galvan A, Wichmann T. 2008. Pathophysiology of parkinsonism. Clin Neurophysiol 119:1459-1474.
    • (2008) Clin Neurophysiol , vol.119 , pp. 1459-1474
    • Galvan, A.1    Wichmann, T.2
  • 23
    • 0035176184 scopus 로고    scopus 로고
    • CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum
    • Gerdeman G, Lovinger DM. 2001. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum. J Neurophysiol 85:468-471.
    • (2001) J Neurophysiol , vol.85 , pp. 468-471
    • Gerdeman, G.1    Lovinger, D.M.2
  • 24
    • 0036233834 scopus 로고    scopus 로고
    • Postsynaptic endocannabinoid release is critical to long-term depression in the striatum
    • Gerdeman GL, Ronesi J, Lovinger DM. 2002. Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nat Neurosci 5:446-451.
    • (2002) Nat Neurosci , vol.5 , pp. 446-451
    • Gerdeman, G.L.1    Ronesi, J.2    Lovinger, D.M.3
  • 25
    • 61449172037 scopus 로고    scopus 로고
    • Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
    • Huang dW, Sherman BT, Lempicki RA. 2009. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44-57.
    • (2009) Nat Protoc , vol.4 , pp. 44-57
    • Huang, dW.1    Sherman, B.T.2    Lempicki, R.A.3
  • 26
    • 0345490815 scopus 로고    scopus 로고
    • Expression of cannabinoid CB1 receptor mRNA in basal ganglia of normal and parkinsonian human brain
    • Hurley MJ, Mash DC, Jenner P. 2003. Expression of cannabinoid CB1 receptor mRNA in basal ganglia of normal and parkinsonian human brain. J Neural Transm 110:1279-1288.
    • (2003) J Neural Transm , vol.110 , pp. 1279-1288
    • Hurley, M.J.1    Mash, D.C.2    Jenner, P.3
  • 28
    • 50049087567 scopus 로고    scopus 로고
    • Molecular mechanisms of l-DOPA-induced dyskinesia
    • Jenner P. 2008. Molecular mechanisms of l-DOPA-induced dyskinesia. Nat Rev Neurosci 9:665-677.
    • (2008) Nat Rev Neurosci , vol.9 , pp. 665-677
    • Jenner, P.1
  • 30
    • 0033982936 scopus 로고    scopus 로고
    • KEGG: kyoto encyclopedia of genes and genomes
    • Kanehisa M, Goto S 2000. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28(1):27-30.
    • (2000) Nucleic Acids Res , vol.28 , Issue.1 , pp. 27-30
    • Kanehisa, M.1    Goto, S.2
  • 32
    • 77951665718 scopus 로고    scopus 로고
    • Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses
    • Kim J, Alger BE. 2010. Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses. Nat Neurosci 13:592-600.
    • (2010) Nat Neurosci , vol.13 , pp. 592-600
    • Kim, J.1    Alger, B.E.2
  • 36
    • 77349086589 scopus 로고    scopus 로고
    • l-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: Temporal and quantitative relationship to the expression of dyskinesia
    • Lindgren HS, Andersson DR, Lagerkvist S, Nissbrandt H, Cenci MA. 2010. l-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: Temporal and quantitative relationship to the expression of dyskinesia. J Neurochem 112:1465-1476.
    • (2010) J Neurochem , vol.112 , pp. 1465-1476
    • Lindgren, H.S.1    Andersson, D.R.2    Lagerkvist, S.3    Nissbrandt, H.4    Cenci, M.A.5
  • 38
    • 84856516709 scopus 로고    scopus 로고
    • The cannabinoid agonist WIN55212-2 decreases l-DOPA-induced PKA activation and dyskinetic behavior in 6-OHDA-treated rats
    • Martinez A, Macheda T, Morgese MG, Trabace L, Giuffrida A. 2012. The cannabinoid agonist WIN55212-2 decreases l-DOPA-induced PKA activation and dyskinetic behavior in 6-OHDA-treated rats. Neurosci Res 72:236-242.
    • (2012) Neurosci Res , vol.72 , pp. 236-242
    • Martinez, A.1    Macheda, T.2    Morgese, M.G.3    Trabace, L.4    Giuffrida, A.5
  • 39
    • 33947611555 scopus 로고    scopus 로고
    • Long-term depression: Multiple forms and implications for brain function
    • Massey PV, Bashir ZI. 2007. Long-term depression: Multiple forms and implications for brain function. Trends Neurosci 30:176-184.
    • (2007) Trends Neurosci , vol.30 , pp. 176-184
    • Massey, P.V.1    Bashir, Z.I.2
  • 40
    • 33745354666 scopus 로고    scopus 로고
    • Microarrays in Parkinson's disease: A systematic approach
    • Miller RM, Federoff HJ. 2006. Microarrays in Parkinson's disease: A systematic approach. NeuroRx 3:319-326.
    • (2006) NeuroRx , vol.3 , pp. 319-326
    • Miller, R.M.1    Federoff, H.J.2
  • 41
    • 35348938494 scopus 로고    scopus 로고
    • Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: Role of CB(1) and TRPV1 receptors
    • Morgese MG, Cassano T, Cuomo V, Giuffrida A. 2007. Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: Role of CB(1) and TRPV1 receptors. Exp Neurol 208:110-119.
    • (2007) Exp Neurol , vol.208 , pp. 110-119
    • Morgese, M.G.1    Cassano, T.2    Cuomo, V.3    Giuffrida, A.4
  • 42
    • 33746105694 scopus 로고    scopus 로고
    • Continuous dopamine-receptor treatment of Parkinson's disease: Scientific rationale and clinical implications
    • Olanow CW, Obeso JA, Stocchi F. 2006. Continuous dopamine-receptor treatment of Parkinson's disease: Scientific rationale and clinical implications. Lancet Neurol 5:677-687.
    • (2006) Lancet Neurol , vol.5 , pp. 677-687
    • Olanow, C.W.1    Obeso, J.A.2    Stocchi, F.3
  • 43
    • 84864134369 scopus 로고    scopus 로고
    • Strong preferences of dopamine and l-DOPA towards lipid head group: Importance of lipid composition and implication for neurotransmitter metabolism
    • Orłowski A, Grzybek M, Bunker A, Pasenkiewicz-Gierula M, Vattulainen I, Männistö PT, Róg T. 2012. Strong preferences of dopamine and l-DOPA towards lipid head group: Importance of lipid composition and implication for neurotransmitter metabolism. J Neurochem 122:681-690.
    • (2012) J Neurochem , vol.122 , pp. 681-690
    • Orłowski, A.1    Grzybek, M.2    Bunker, A.3    Pasenkiewicz-Gierula, M.4    Vattulainen, I.5    Männistö, P.T.6    Róg, T.7
  • 44
    • 43449092524 scopus 로고    scopus 로고
    • The cannabinoid system in Parkinson's disease: Multiple targets to motor effects
    • Papa SM. 2008. The cannabinoid system in Parkinson's disease: Multiple targets to motor effects. Exp Neurol 211:334-338.
    • (2008) Exp Neurol , vol.211 , pp. 334-338
    • Papa, S.M.1
  • 48
    • 80052967562 scopus 로고    scopus 로고
    • Endocannabinoid-mediated synaptic plasticity and addiction-related behavior
    • Sidhpura N, Parsons LH. 2011. Endocannabinoid-mediated synaptic plasticity and addiction-related behavior. Neuropharmacology 61:1070-1087.
    • (2011) Neuropharmacology , vol.61 , pp. 1070-1087
    • Sidhpura, N.1    Parsons, L.H.2
  • 49
    • 0031929438 scopus 로고    scopus 로고
    • Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
    • Tsou K, Brown S, Sañudo-Peña MC, Mackie K, Walker JM. 1998. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83:393-411.
    • (1998) Neuroscience , vol.83 , pp. 393-411
    • Tsou, K.1    Brown, S.2    Sañudo-Peña, M.C.3    Mackie, K.4    Walker, J.M.5
  • 50
    • 0035942271 scopus 로고    scopus 로고
    • Significance analysis of microarrays applied to the ionizing radiation response
    • Tusher VG, Tibshirani R, Chu G. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98:5116-5121.
    • (2001) Proc Natl Acad Sci USA , vol.98 , pp. 5116-5121
    • Tusher, V.G.1    Tibshirani, R.2    Chu, G.3
  • 51
    • 77949912308 scopus 로고    scopus 로고
    • Changes in firing rate and pattern of GABAergic neurons in subregions of the substantia nigra pars reticulata in rat models of Parkinson's disease
    • Wang Y, Zhang Q, Liu J, Ali U, Gui Z, Hui Y, Chen L, Wang T. 2010. Changes in firing rate and pattern of GABAergic neurons in subregions of the substantia nigra pars reticulata in rat models of Parkinson's disease. Brain Res 1324:54-63.
    • (2010) Brain Res , vol.1324 , pp. 54-63
    • Wang, Y.1    Zhang, Q.2    Liu, J.3    Ali, U.4    Gui, Z.5    Hui, Y.6    Chen, L.7    Wang, T.8
  • 52
    • 84855306692 scopus 로고    scopus 로고
    • Genome-wide gene expression analysis suggests an important role of suppressed immunity in pathogenesis of Kashin-Beck disease
    • Wang S, Guo X, Wu XM, Lammi MJ. 2012. Genome-wide gene expression analysis suggests an important role of suppressed immunity in pathogenesis of Kashin-Beck disease. PLoS One 7:e28439.
    • (2012) PLoS One , vol.7
    • Wang, S.1    Guo, X.2    Wu, X.M.3    Lammi, M.J.4
  • 53
    • 0036070538 scopus 로고    scopus 로고
    • l-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: Relation to motor and cellular parameters of nigrostriatal function
    • Winkler C, Kirik D, Björklund A, Cenci MA. 2002. l-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: Relation to motor and cellular parameters of nigrostriatal function. Neurobiol Dis 10:165-186.
    • (2002) Neurobiol Dis , vol.10 , pp. 165-186
    • Winkler, C.1    Kirik, D.2    Björklund, A.3    Cenci, M.A.4
  • 54
    • 79960897042 scopus 로고    scopus 로고
    • Genome-wide gene expression analysis suggests an important role of hypoxia in the pathogenesis of endemic osteochondropathy Kashin-Beck disease
    • Zhang F, Guo X, Wang W, Yan H, Li C. 2011. Genome-wide gene expression analysis suggests an important role of hypoxia in the pathogenesis of endemic osteochondropathy Kashin-Beck disease. PLoS One 6:e22983.
    • (2011) PLoS One , vol.6
    • Zhang, F.1    Guo, X.2    Wang, W.3    Yan, H.4    Li, C.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.